REM1

Across TCGA pan-cancer cohorts, REM1 mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated REM1 data layer compared with 25 for mass-spec protein and 6 for mutation status.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher REM1 mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated REM1 expression acts as an unfavorable survival marker.

LUAD, PDAC, and GBM are the cancer types where REM1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Median	III,IV	0.333	0.897	.013	20	view →
PDAC	DFS	Median	II,III,IV	0.203	0.656	.004	12	view →
GBM	OS	Median	All	0.293	0.504	.048	2	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

REM1–LUAD (OS)

Open the LUAD breakdown →